Assembly Bill A2991

2015-2016 Legislative Session

Prohibits a pharmacist from substituting any anti-epileptic drug for a prescribed anti-epileptic drug without the informed consent of the prescriber and patient

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Assembly Committee


  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions

co-Sponsors

multi-Sponsors

2015-A2991 (ACTIVE) - Details

Current Committee:
Assembly Higher Education
Law Section:
Public Health Law
Laws Affected:
Add §3346, Pub Health L; amd §6816-a, Ed L
Versions Introduced in Other Legislative Sessions:
2009-2010: A3528
2011-2012: A6574
2013-2014: A3062
2017-2018: A3719
2019-2020: A3982
2021-2022: A1982
2023-2024: A635

2015-A2991 (ACTIVE) - Summary

Prohibits a pharmacist from substituting any anti-epileptic drug for the prescribed anti-epileptic drug without notification of and the informed consent of the prescriber and patient or such patient's parent, guardian or spouse.

2015-A2991 (ACTIVE) - Bill Text download pdf

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  2991

                       2015-2016 Regular Sessions

                          I N  A S S E M B L Y

                            January 20, 2015
                               ___________

Introduced  by  M.  of  A.  AUBRY, ROSENTHAL, BENEDETTO, CLARK, SCHIMEL,
  JAFFEE -- Multi-Sponsored by -- M.  of  A.  BRENNAN,  CAHILL,  COLTON,
  DUPREY,  KOLB,  LOPEZ, MARKEY, McLAUGHLIN, PERRY, RIVERA, SCARBOROUGH,
  TEDISCO, THIELE -- read once and referred to the Committee  on  Higher
  Education

AN ACT to amend the public health law and the education law, in relation
  to  requiring notification of and the informed consent of the prescri-
  ber and the patient prior to the substitution of a prescribed anti-ep-
  ileptic drug

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1.   The public health law is amended by adding a new section
3346 to read as follows:
  S 3346. ANTI-EPILEPTIC DRUG PRODUCT SELECTION PROHIBITED. 1.  AS  USED
IN THIS SECTION:
  (A) "ANTI-EPILEPTIC DRUG" MEANS (I) ANY DRUG PRESCRIBED FOR THE TREAT-
MENT OF EPILEPSY OR (II) A DRUG USED TO TREAT OR PREVENT SEIZURES.
  (B)  "EPILEPSY" MEANS A NEUROLOGICAL CONDITION CHARACTERIZED BY RECUR-
RENT SEIZURES.
  (C) "SEIZURE" MEANS AN ACUTE CLINICAL  CHANGE  SECONDARY  TO  A  BRIEF
DISTURBANCE IN THE ELECTRICAL ACTIVITY OF THE BRAIN.
  (D)  "INTERCHANGE"  MEANS  THE SUBSTITUTION OF ONE VERSION OF THE SAME
ANTI-EPILEPTIC THERAPEUTIC PRODUCT, INCLUDING A GENERIC VERSION FOR  THE
PRESCRIBED  BRAND, A BRAND VERSION FOR THE PRESCRIBED GENERIC VERSION, A
GENERIC VERSION BY ONE MANUFACTURER FOR A GENERIC VERSION BY A DIFFERENT
MANUFACTURER, A DIFFERENT FORMULATION OF THE  PRESCRIBED  ANTI-EPILEPTIC
DRUG  OR  A  DIFFERENT  ANTI-EPILEPTIC  THERAPEUTIC DRUG PRODUCT FOR THE
ANTI-EPILEPTIC PRODUCT ORIGINALLY PRESCRIBED.
  2. NO PHARMACIST SHALL INTERCHANGE AN ANTI-EPILEPTIC  DRUG  OR  FORMU-
LATION OF AN ANTI-EPILEPTIC DRUG, BRAND OR GENERIC, FOR THE TREATMENT OF
EPILEPTIC  SEIZURES  WITHOUT  THE  PRIOR  NOTIFICATION OF AND THE SIGNED

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD07631-01-5
              

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.